ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850 | +2.8% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,800 | +25.3% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,436 | -16.7% | 89,700 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $1,723 | -99.9% | 89,700 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $1,236,000 | -35.5% | 89,700 | -40.3% | 0.00% | -33.3% |
| Q2 2022 | $1,915,000 | -20.1% | 150,200 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $2,396,000 | -18.5% | 150,200 | +14.2% | 0.01% | -14.3% |
| Q4 2021 | $2,939,000 | -23.4% | 131,500 | +1.7% | 0.01% | -36.4% |
| Q3 2021 | $3,836,000 | -30.5% | 129,300 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $5,521,000 | +137.7% | 129,300 | +138.1% | 0.02% | +100.0% |
| Q1 2021 | $2,323,000 | -10.9% | 54,300 | +14.8% | 0.01% | -20.0% |
| Q4 2020 | $2,607,000 | +55.5% | 47,300 | -35.8% | 0.01% | +42.9% |
| Q3 2020 | $1,677,000 | – | 73,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |